Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
5.66
+0.03 (0.53%)
Oct 24, 2025, 2:45 PM HKT
HKG:1066 Revenue
Shandong Weigao Group Medical Polymer Company had revenue of 6.64B CNY in the half year ending June 30, 2025, a decrease of -3.68%. This brings the company's revenue in the last twelve months to 13.10B, up 0.99% year-over-year. In the year 2024, Shandong Weigao Group Medical Polymer Company had annual revenue of 13.09B, down -1.08%.
Revenue (ttm)
13.10B CNY
Revenue Growth
+0.99%
P/S Ratio
1.78
Revenue / Employee
1.03M CNY
Employees
12,719
Market Cap
25.61B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13.09B | -142.38M | -1.08% |
| Dec 31, 2023 | 13.23B | -518.02M | -3.77% |
| Dec 31, 2022 | 13.75B | 538.53M | 4.08% |
| Dec 31, 2021 | 13.21B | 1.59B | 13.65% |
| Dec 31, 2020 | 11.62B | 1.24B | 11.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 71.34B |
| BeOne Medicines AG | 35.81B |
| Sino Biopharmaceutical | 33.49B |
| Alibaba Health Information Technology | 32.81B |
| CSPC Pharmaceutical Group | 28.49B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |